HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The significance of GATA3 expression in breast cancer: a 10-year follow-up study.

Abstract
GATA3 is a transcription factor closely associated with estrogen receptor alpha in breast carcinoma, with a potential prognostic utility. This study investigated the immunohistochemical expression of GATA3 in estrogen receptor alpha-positive and estrogen receptor alpha-negative breast carcinomas. One hundred sixty-six cases of invasive breast carcinomas with 10-year follow-up information were analyzed. Positive GATA3 and estrogen receptor alpha cases were defined as greater than 20% of cells staining. Time to cancer recurrence and time to death were analyzed with survival methods. Of 166 patients, 40 were estrogen receptor alpha negative and 121 estrogen receptor alpha positive. Thirty-eight (23%) recurrences and 51 (31%) deaths were observed. In final multivariable analyses, GATA3-positive tumors had about two thirds the recurrence risk of GATA3-negative tumors (hazard ratio = 0.65, P = .395) and comparable mortality risk (hazard ratio = 0.86, P = .730). In prespecified subgroup analyses, the protective effect of GATA3 expression was most pronounced among estrogen receptor alpha-positive patients who received tamoxifen (hazard ratio = 0.57 for recurrence and 0.68 for death). We found no statistically significant differences in recurrence or survival rates between GATA3-positive and GATA3-negative tumors. However, there was a suggestion of a modest-to-strong protective effect of GATA3 expression among estrogen receptor alpha-positive patients receiving hormone therapy.
AuthorsVincenzo Ciocca, Constantine Daskalakis, Robin M Ciocca, Alejandra Ruiz-Orrico, Juan P Palazzo
JournalHuman pathology (Hum Pathol) Vol. 40 Issue 4 Pg. 489-95 (Apr 2009) ISSN: 1532-8392 [Electronic] United States
PMID19084267 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Estrogen Receptor alpha
  • GATA3 Transcription Factor
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
Topics
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms (metabolism, mortality, pathology)
  • Estrogen Receptor alpha (metabolism)
  • Female
  • Follow-Up Studies
  • GATA3 Transcription Factor (biosynthesis)
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Neoplasm Recurrence, Local (metabolism)
  • Prognosis
  • Selective Estrogen Receptor Modulators (therapeutic use)
  • Tamoxifen (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: